两家公司表示,在合作的初始阶段,Ares开发了一个数字抗感染平台,将微生物学实验室实践与先进的生物信息学和人工智能方法相结合,以帮助识别有效的抗菌化合物...查看全文
蹊之美股生物医药2021-10-08 00:15
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Voyager Therapeutics (NASDAQ:VYGR) +56%
Acer Therapeutics (NASDAQ:ACER) +16%
Molecular Partners (NASDAQ:MOLN) +10%
Rafael (NYSE:RFL) +6%
Arcturus Therapeutics (NASDA...查看全文
东哥_Singapore2021-03-08 23:42
$Jaguar Health(JAGX)$ 给力点啊,速度冲2.5!刚才在2.9的OPGN跟1.85的你之间,最后选的你!不要让我失望啊!OPGN已经爆拉了!!!$OpGen(OPGN)$查看全文
$OpGen(OPGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001079973-22-000770 Size: 4 KB 网页链接
$OpGen(OPGN)$ 8-K Current report, item 5.07 Accession Number: 0001079973-22-000769 Act: 34 Size: 207 KB 网页链接
$OpGen(OPGN)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001079973-22-000739 Act: 33 Size: 85 KB 网页链接
$OpGen(OPGN)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001079973-22-000737 Act: 33 Size: 129 KB 网页链接
$OpGen(OPGN)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001079973-22-000722 Act: 34 Size: 26 KB 网页链接
$OpGen(OPGN)$ 8-K Current report, items 1.01, 2.03, and 9.01 Accession Number: 0001079973-22-000652 Act: 34 Size: 1 MB 网页链接
$OpGen(OPGN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001079973-22-000582 Act: 34 Size: 5 MB 网页链接
$OpGen(OPGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001079973-22-000577 Act: 34 Size: 290 KB 网页链接
$OpGen(OPGN)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001079973-22-000497 Act: 34 Size: 37 KB 网页链接
$OpGen(OPGN)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001079973-22-000499 Act: 34 Size: 28 KB 网页链接